Valuation: Seer, Inc.

Market Cap 119M 104M 95.78M 88.05M 167M 11.43B 170M 1.14B 449M 5.59B 446M 436M 19.25B P/E 2026 *
-2.07x
P/E 2027 * -2.2x
Enterprise Value 119M 104M 95.78M 88.05M 167M 11.43B 170M 1.14B 449M 5.59B 446M 436M 19.25B EV / Sales 2026 *
7.31x
EV / Sales 2027 * 5.67x
Free-Float
85.54%
Yield 2026 *
-
Yield 2027 * -
1 week-0.92%
Current month+30.12%
1 month+26.32%
3 months+10.20%
6 months+13.09%
Current year+18.03%
1 week 2.14
Extreme 2.14
2.2
1 month 1.55
Extreme 1.55
2.34
Current year 1.55
Extreme 1.55
2.34
1 year 1.55
Extreme 1.55
2.41
3 years 1.46
Extreme 1.455
5.65
5 years 1.46
Extreme 1.455
45.85
10 years 1.46
Extreme 1.455
86.55
Manager TitleAgeSince
Chief Executive Officer 57 2018-02-28
Director of Finance/CFO 58 2020-04-30
Chief Operating Officer - -
Director TitleAgeSince
Chairman 57 2020-08-31
Director/Board Member 76 2017-11-30
Director/Board Member 70 2017-11-30
Date Insider Type Main position Quantity % Market Cap.
07-07Sell

Director

-10,660 0.0193%
05-19Sell

Chief Financial Officer

-7,303 0.0129%
05-07Free

Executive/Senior Manager

300,000 0.5317%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.92%+2.86%-54.81% 119M
+0.13%+5.41%+12.66%-1.15% 26.6B
-1.36%+5.08%+25.88%-3.71% 7.6B
-8.18%+1.47%+93.42%+176.23% 4.2B
-0.68%+4.06%+10.23%-46.54% 2.85B
+2.87%+18.48%+101.30%+76.88% 2.53B
-6.39%-12.14%+158.13%+116.23% 2.08B
-4.62%-12.57%+19.23%+12.84% 1.73B
+7.24%-1.48%-12.05%+40.19% 1.24B
+1.12%-6.78%+97.64%+65.43% 939M
Average -0.99%-1.29%+50.93%+38.16% 4.99B
Weighted average by Cap. -0.94%+3.09%+33.07%+22.28%

Financials

2026 *2027 *
Net sales 16.25M 14.21M 13.11M 12.05M 22.83M 1.56B 23.22M 156M 61.39M 764M 61.03M 59.69M 2.63B 20.95M 18.32M 16.9M 15.53M 29.43M 2.02B 29.93M 202M 79.15M 985M 78.68M 76.95M 3.4B
Net income -58.65M -51.28M -47.3M -43.48M -82.39M -5.64B -83.8M -565M -222M -2.76B -220M -215M -9.51B -55.7M -48.7M -44.92M -41.3M -78.25M -5.36B -79.58M -536M -210M -2.62B -209M -205M -9.03B
Net Debt - -
Logo Seer, Inc.
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Employees
124
Date Price Change Volume
26-07-15 US$2.160 0.00% 310,397
26-07-14 US$2.160 -0.46% 142,655
26-07-13 US$2.170 0.00% 365,132
26-07-10 US$2.170 -1.36% 301,330
26-07-09 US$2.200 +0.92% 419,416
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.160USD
Average target price
4.000USD
Spread / Average Target
+85.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEER Stock